ATE253114T1 - Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis - Google Patents

Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis

Info

Publication number
ATE253114T1
ATE253114T1 AT91918802T AT91918802T ATE253114T1 AT E253114 T1 ATE253114 T1 AT E253114T1 AT 91918802 T AT91918802 T AT 91918802T AT 91918802 T AT91918802 T AT 91918802T AT E253114 T1 ATE253114 T1 AT E253114T1
Authority
AT
Austria
Prior art keywords
neisseria
neisseria gonorrhoeae
iron
regulated
outer membrane
Prior art date
Application number
AT91918802T
Other languages
English (en)
Inventor
P Frederick Sparling
Cynthia Nau Cornelissen
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE253114T1 publication Critical patent/ATE253114T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT91918802T 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis ATE253114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57218790A 1990-08-23 1990-08-23
PCT/US1991/006026 WO1992003467A1 (en) 1990-08-23 1991-08-23 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis

Publications (1)

Publication Number Publication Date
ATE253114T1 true ATE253114T1 (de) 2003-11-15

Family

ID=24286735

Family Applications (2)

Application Number Title Priority Date Filing Date
AT91918802T ATE253114T1 (de) 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis
AT02028655T ATE439859T1 (de) 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02028655T ATE439859T1 (de) 1990-08-23 1991-08-23 Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff

Country Status (10)

Country Link
US (1) US7582730B2 (de)
EP (2) EP0546118B1 (de)
JP (3) JP3532563B2 (de)
AT (2) ATE253114T1 (de)
AU (1) AU8747791A (de)
CA (1) CA2087958C (de)
DE (2) DE69133334T2 (de)
DK (2) DK1378245T3 (de)
ES (2) ES2329979T3 (de)
WO (1) WO1992003467A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086896A (en) * 1990-07-16 2000-07-11 Imclone Systems Incorporated Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxins
US6887482B2 (en) 1990-07-16 2005-05-03 The University Of North Carolina At Chapel Hill Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
FR2724936A1 (fr) * 1994-09-22 1996-03-29 Pasteur Merieux Serums Vacc Recepteur lactoferrine d'helicobacter
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
WO1997013784A1 (fr) * 1995-10-09 1997-04-17 Pasteur Merieux Serums Et Vaccins Recepteur lactoferrine d'helicobacter
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP2261338A3 (de) * 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
EP1939215A1 (de) 1998-10-22 2008-07-02 The University of Montana Omp85-Proteien von Neisseria Gonorrhoeae und Neisseria Meningitidis, Zusammensetzungen damit und ihre Verwendungsverfahren
ES2310776T3 (es) * 1998-10-22 2009-01-16 The University Of Montana Composiciones de vacuna que comprenden proteinas omp de neisseria gonorrhoeae y de neisseria meningitidis.
WO2000023595A1 (en) * 1998-10-22 2000-04-27 The University Of Montana Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
US6610306B2 (en) 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
EP1069133A1 (de) 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis Zusammensetzungen und ihre Verwendungen als anti-infektionsmitteln
JP2004508801A (ja) * 1999-10-29 2004-03-25 カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ ナイセリア抗原性ペプチド
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
CA2503946C (en) 2002-11-01 2016-08-16 Glaxosmithkline Biologicals S.A. Drying process
EP1667712B1 (de) 2003-10-02 2010-07-21 GlaxoSmithKline Biologicals S.A. B. pertussis antigene und ihre verwendung bei der vakzinierung
NZ546430A (en) 2003-10-02 2009-04-30 Novartis Vaccines & Diagnostic Liquid vaccines for multiple meningococcal serogroups
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
CA2654706A1 (en) 2006-06-12 2007-12-21 Nathalie Devos Neisseria meningitidis lipooligosaccharide vaccine
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
CA2818173C (en) 2010-11-30 2022-05-03 Genentech, Inc. Low affinity blood brain barrier receptor antibodies and uses therefor
CN109716130B (zh) * 2016-07-18 2023-05-23 赛尔伊迪克斯公司 抗原偶联的杂交试剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5912336A (en) * 1990-08-23 1999-06-15 University Of North Carolina At Chapel Hill Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
FR2692592B1 (fr) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.

Also Published As

Publication number Publication date
DE69133334T2 (de) 2004-05-13
JP3532563B2 (ja) 2004-05-31
EP1378245A2 (de) 2004-01-07
WO1992003467A1 (en) 1992-03-05
JPH06500562A (ja) 1994-01-20
DK0546118T3 (da) 2004-02-16
DK1378245T3 (da) 2009-10-26
ATE439859T1 (de) 2009-09-15
ES2329979T3 (es) 2009-12-03
CA2087958C (en) 2007-05-15
ES2210228T3 (es) 2004-07-01
AU8747791A (en) 1992-03-17
JP2005239548A (ja) 2005-09-08
US7582730B2 (en) 2009-09-01
DE69133622D1 (de) 2009-10-01
EP1378245B1 (de) 2009-08-19
CA2087958A1 (en) 1992-02-24
EP1378245A3 (de) 2004-01-14
JP2002186489A (ja) 2002-07-02
EP0546118A4 (en) 1993-07-14
DE69133334D1 (de) 2003-12-04
EP0546118B1 (de) 2003-10-29
EP0546118A1 (de) 1993-06-16
US20070065453A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
ATE253114T1 (de) Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis
DE60041981D1 (de) Neisseria meningitidis-serumgruppen b und c-antigene sowie ein zusätzliches antigen enthaltende zusammensetzungen
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
IL153593A (en) Pharmaceutical composition containing a soluble ctla4 mutant molecule
ATE167516T1 (de) Colostrum fraktion und ihre verwendung als additiv beim zellkulturmedium
KR880701564A (ko) 스타버스트 콘쥬게이트
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
CA2056279A1 (en) Cell-free receptor binding assays, the production and use thereof
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
BR9811475A (pt) Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae
ES2156602T3 (es) Expresion de albumina en levaduras.
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DE69111401D1 (de) Tert-Butyloxycarbonyl-L-Tyrosyl-Peptidoglycanmonomer und deren 125 I-markiertes Derivat, deren Herstellung und Verwendung.
FI913475L (fi) Klass ii protein med immunologiska baerar- och foerstaerkningsegenskaper fraon yttermembranen i neisseria meningitidis och vaccin innehaollande detta.
FI913473A0 (fi) Ett klass ii protein av ytmembranet av neisseria meningitidis med egenskaper av en immunologisk baerare och med immunrespons befraemjande egenskaper.
ES274547U (es) Almohadilla plegable
MX9704110A (es) Nueva proteina de membrana helicobacter pylori p76.
ES1033817U (es) Soporte armable para bolsas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0546118

Country of ref document: EP

EELA Cancelled due to lapse of time